Early HBcrAg and Anti-HBc Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue Cessation-A Pooled Analysis of Two Clinical Trials

Edo J. Dongelmans*, Jordan J. Feld, Andre Boonstra, Sylvia M. Brakenhoff, David Wong, Colina Yim, Mark Claassen, Pieter Honkoop, Bettina E. Hansen, Robert A. de Man, Scott Fung, Thomas Berg, Florian van Boemmel, Harry L. A. Janssen, Milan J. Sonneveld

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Scopus)
5 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Early HBcrAg and Anti-HBc Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue Cessation-A Pooled Analysis of Two Clinical Trials'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology